{"id":"W2220471922","doi":"10.2217/mmt.15.13","title":"Oncolytics Biotech ® Inc.: REOLYSIN ® for Melanoma Therapy","year":2015,"lang":"en","type":"editorial","venue":"Melanoma Management","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Cancer therapy; Melanoma; Cancer; Virology; Cancer research; Immunology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002865509,0.002287232,0.001095899,0.001743706,0.001229735,0.003794786,0.001348119,0.006182331,0.0206296],"category_scores_gemma":[0.005153373,0.0006068699,0.00119254,0.0005858305,0.001093037,0.002957745,0.0007528741,0.008369611,0.02050284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001602714,"about_ca_system_score_gemma":0.001339408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005549481,"about_ca_topic_score_gemma":0.001286205,"domain_scores_codex":[0.99856,0.0001317876,0.000144389,0.0001664137,0.0009104377,0.00008702818],"domain_scores_gemma":[0.9965011,0.001047288,0.0003087377,0.0001159205,0.001341517,0.0006853925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002986231,0.00001770401,0.00001581123,0.0001952394,0.000006289459,0.00009084766,0.00001002824,0.00002972941,0.0002824896,0.000530492,0.985486,0.01330551],"study_design_scores_gemma":[0.00002248176,0.00002126425,0.00009071719,0.0001102888,0.000008338721,0.0001732918,0.000009930905,0.00005931211,0.0002200566,0.0004675529,0.998811,0.000005823331],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.000125437,0.02075439,0.0004107371,0.02530105,0.9414865,0.00004729501,0.00009621048,0.0001731926,0.01160517],"genre_scores_gemma":[0.001370243,0.02269178,0.0003443051,0.02197753,0.8593456,0.00003748835,0.0001223204,0.0001073896,0.09400349],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.0206296,"threshold_uncertainty_score":0.06901294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02150293345390318,"score_gpt":0.3040468738097407,"score_spread":0.2825439403558375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}